Concepedia

Samantha M. Bevill

SM

9

Publications

427

Citations

9

H-Index

2017

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

Harvard University

Massachusetts General Hospital

Broad Institute

Dana-Farber Cancer Institute

Samantha M. Bevill is an author at University of North Carolina at Chapel Hill specializing in natural sciences, medicine, and molecular biology.

ORCID

Top concepts

Publications per year

2017–2023

9

Publications

9

Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex

Jon S. Zawistowski, Samantha M. Bevill, Daniel R. Goulet et al. · Cancer Discovery · 2017 · 180 citations

GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer

Samantha M. Bevill, José F. Olivares-Quintero, Noah Sciaky et al. · Molecular Cancer Research · 2019 · 75 citations · Full text

, , +24

Extended-representation bisulfite sequencing of gene regulatory elements in multiplexed samples and single cells

Sarah J. Shareef, Samantha M. Bevill, Ayush T. Raman et al. · Nature Biotechnology · 2021 · 43 citations · Full text

, , +15

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer

Amanda E.D. Van Swearingen, Maria J. Sambade, Marni B. Siegel et al. · Neuro-Oncology · 2017 · 40 citations · Full text

Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer

Kyla Collins, Timothy J. Stuhlmiller, Jon S. Zawistowski et al. · Oncotarget · 2018 · 31 citations · Full text

, , +18

Rows per page

1–5 of 9